Clinical Trial

LEAP 2 Chronic EFS

Recruiting
View on ClinicalTrials.gov →
Summary
Prospective, single-arm, non-randomized, unblinded, chronic feasibility study designed to evaluate the safety and performance of the AVEIR™ Conduction System Pacing (CSP) Leadless Pacemaker system.
Protocol Amendment History 3 changes
critical Trial status changed: Active, Not Recruiting → Recruiting 2026-07-16
notable Enrollment increased: 20 -> 30 participants 2026-07-16
notable Primary completion pushed: 2026-03-16 -> 2026-09 2026-07-16
Trial Details
NCT Number NCT07287423
Lead Sponsor Abbott Medical Devices
Conditions Cardiac Pacemaker, Cardiac Rhythm Disorder, Bradycardia
Enrollment 30 participants
Start Date 2025-12-13
Primary Completion 2026-09 (estimated)
Study Completion 2028-12 (estimated)
Updated on ClinicalTrials.gov 2026-07-15